PatientsVille.com Logo

MUSCULAR WEAKNESS and Dilaudid

PatientsVille

MUSCULAR WEAKNESS Symptoms and Causes

Myasthenia gravis is a disease that causes weakness in your voluntary muscles. These are the muscles that you control. For example, you may have weakness in the muscles for eye movement, facial expressions, and swallowing. You can also have weakness in other muscles. This weakness gets worse with activity, and better with rest.

Myasthenia gravis is an autoimmune disease. Your body's immune system makes antibodies that block or change some of the nerve signals to your muscles. This makes your muscles weaker.

Other conditions can cause muscle weakness, so myasthenia gravis can be hard to diagnose. Tests used to make a diagnosis include blood, nerve, muscle, and imaging tests.

With treatment, the muscle weakness often gets much better. Medicines can help improve nerve-to-muscle messages and make muscles stronger. Other drugs keep your body from making so many abnormal antibodies. These medicines can have major side effects, so they should be used carefully. There are also treatments which filter abnormal antibodies from the blood or add healthy antibodies from donated blood. Sometimes, surgery to take out the thymus gland helps.

Some people with myasthenia gravis go into remission. This means that they do not have symptoms. The remission is usually temporary, but sometimes it can be permanent.

NIH: National Institute of Neurological Disorders and Stroke

Check out the latest treatments for MUSCULAR WEAKNESS

MUSCULAR WEAKNESS treatment research studies

Dilaudid clinical trials, surveys and public health registries


Find Drug Side Effect reports



Dilaudid Side Effects

Nausea (50)
Vomiting (47)
Pain (35)
Pruritus (33)
Overdose (33)
Headache (31)
Dyspnoea (28)
Substance Abuse (27)
Constipation (27)
Unresponsive To Stimuli (26)
Respiratory Arrest (25)
Death (25)
Dizziness (25)
Confusional State (23)
Malaise (22)
Rash (21)
Inadequate Analgesia (21)
Somnolence (20)
Cardio-respiratory Arrest (20)
Abdominal Pain (20)
Loss Of Consciousness (19)
Incorrect Dose Administered (18)
Respiratory Depression (18)
Hyperhidrosis (18)
Dehydration (18)
Back Pain (17)
Fatigue (17)
Hypotension (17)
Hallucination (17)
Weight Decreased (17)
Fall (16)
Diarrhoea (16)
Blood Pressure Decreased (15)
Pneumonia (15)
Condition Aggravated (15)
Lethargy (15)
Sedation (14)
Respiratory Rate Decreased (14)
Cardiac Arrest (14)
Feeling Abnormal (14)
Pulmonary Embolism (13)
Asthenia (13)
Anxiety (12)
Depressed Level Of Consciousness (12)
Cyanosis (11)
Coma (11)
Erythema (11)
Pain In Extremity (11)
Oxygen Saturation Decreased (11)
Insomnia (11)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Also, Delaudid makes me itch from head to toe with no visable signs or redness or rash. I have to have Benedryl administered with each dose.

Good for pain, memory problems

Had no bad side affects i have hepc got from bodbuilding buy growth homone from china had 7 surgerys tired perocet no help then dilaudid it works get no nausea hardly in pain an i function just normal that god for it cos both my nephew are austic i

Hi laja- i had the exact same experience recently, but worse. i'd love to speak to you further to compare symptoms and what the doctor's are saying. let me know if you have any updates, and i hope you feel better!

I am taking 16 and more dilaudid number 8 mg for cellulits and am still in pain it requires 5 8s just to get out of bed the drug only works for a period of two hours and thats taking two every two hours. Iam more afraid of the pain than i am of any s

I have an interthecal pain pump that gives me 10 mg of Dilaudid every 24 hours contstant. I have severe swelling and edema of the lower legs and feet. Is this a normal side effect of this medication? My medication was recently changed from Morphine

I presented in the ER with severe back pain. I was in such a position to have suggested that I had actually crushed 1 or more vertebrae as a result of a parachuting accident. They gave me dilaudid for a pain level of 9.5/10. When they began the IV

I was treated in er for pain with 2 stacked doses of dilaudid equals 3 mg. given with zofran for nausea. i stopped breathing. they gave me narcan and came out of it, but i had severe trembling legs and extremities with severe hyperventilati

It took away the pain. Left me with depression, constipation, and loss of apetitie. Id take it for pain mgmt again, cause i hate pain. But don't want to ever have to take it again.

Look up Dilaudid Side Effects. Hallucinations and Psych problems have been reported.

<b><span style='font-weight: normal;'><b>After 6 weeks of oral lamisil I experienced</b>eczema, muscle weakness, asthma, bloody bowels, lower abdominal pain, dizziness, extreme f

<strong></strong><span style='color: #ffa500;'>I am experiencing severe muscular <span style='color: #0000ff;'>pain/muscle tighteningin the diaphragm and sometimes &

<strong>I am on Cipralex now for about 2-3 months -10mg in the morning for depression, and now am experiencing chronic muscle weakness, chronic pain in both wrists and left hip, chronic fatigue, nausea, constant dizziness, tremors/shaky, restle

2 patients given thiocolchicoside reported of muscular stiffness,uneasiness,insomnia,breathlessness and feeling of restlessness, 2 out of 5 patients have reported such experiences after consuming thiocolchicoside.i strongly recommend to withdraw this

Afeccion cardiaca,pues a pesar de hacer ejercicio se me bloquearon las arterias,por mucho colesterol y tuvieron que hacerme un cateterismo, tengo once aos de que me detectaron la enfermedad. He perdido masa muscular pero nado ycamino dos o tres ve

After 18 months, great fatigue and muscular pain. Is this due to Intragam? consultant thinks I'm being fussy

After a 1 week course of Trimethoprim 200mg. I developed mild thrush on day3, muscle weakness for 1 day on the day after completion of the course and, 3 days after completion generalised urticaria. Not sure if this is delayed sensitivity but I assu

After finnishing the dose for Artequin I started feeling, body twitching, weakness,dizzness, body cramps, headache, neck pain, sore joints and now am at my sixth day after the dose and still experiencing the side effects..

After my first injection on Friday three weeks ago I experienced numbness and weakness Sunday night after injection along with a fever and night sweats. Went back to doctor on Tuesday and had an ultrasound to see if blockages or blood clots everythin

After takin tablets, i am feelimg somewhat uneasyness, feeling weakness, food intake is reduced

MUSCULAR WEAKNESS Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Not yet recruiting Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study
Conditions: Healthy;   Human;   Adult;   Parturient
Interventions: Drug: Hydromorphone 25mcg;   Drug: Hydromorphone 50mcg;   Drug: Hydromorphone 100mcg;   Drug: Hydromorphone 200mcg
Outcome Measures: 24hr post-partum IV opioid requirement;   Oxygen saturation, need for supplemental oxygen;   Nausea and vomiting requiring rescue medication;   Hypothermia (body temperature < 95F/35C);   Visual disturbances;   Pruritus;   Intraoperative vasopressor use
2 Recruiting Study of Respiratory Depression When Using a Hydromorphone Pain Protocol
Conditions: Pain;   Respiratory Depression
Interventions: Drug: Hydromorphone;   Drug: Usual care group
Outcome Measures: Respiratory Depression;   Successful treatment of patient pain;   Change in VAS score;   Hypoxia;   Hypotension;   Allergic reaction to study drug;   Serious Adverse Events
3 Recruiting Association Between Body Size and Response to Hydromorphone in ED
Condition: Pain
Intervention: Drug: Hydromorphone
Outcome Measures: Association between pain scale change and TBW/BMI;   Association between change in pain at 15 minutes,;   pain treatment satisfaction at 30 min;   adverse events (low SatO2<92%, SBP< 90mmHg);   side effects (nausea, vomit, itching);   influence of gender on the association between TBW, BMI and response to iv hydromorphone;   influence of race/ethnicity, and genetic factors on the association between TBW, BMI and response to iv hydromorphone;   influence of genetic factors on the association between TBW, BMI and response to iv hydromorphone;   influence of age on the association between TBW/BMI and response to hydromorphone
4 Not yet recruiting Intrathecal Hydromorphone for Pain Control After Cesarean Section
Conditions: Pain;   Cesarean Section
Interventions: Drug: Intrathecal morphine;   Drug: Intrathecal hydromorphone
Outcome Measures: Post operative fentanyl PCA consumption;   Time to initial PCA use;   Pain score;   Patient satisfaction score;   Side effects
5 Recruiting Titration of Intravenous Hydromorphone
Condition: Acute Severe Pain
Intervention: Drug: Hydromorphone
Outcome Measure: Frequency of different patterns of opioid request
6 Recruiting Methadone and Hydromorphone For Spinal Surgery
Conditions: Hydromorphone Use;   Acute Postoperative Pain;   Patient Satisfaction;   Chronic Persistent Surgical Pain
Interventions: Drug: Methadone;   Drug: Hydromorphone
Outcome Measures: Hydromorphone use at 24 hours;   Hydromorphone use second 24 hours;   Hydromorphone use third 24 hours;   Pain scores postanesthesia care unit (PACU) arrival;   Pain scores 1 hour after PACU arrival;   Pain scores 2 hours after PACU arrival;   Pain scores 4 hours after PACU arrival;   Pain scores on postoperative day one;   Pain scores on postoperative day 2;   Pain scores postoperative day 3;   Patient satisfaction scores;   Chronic persistent surgical pain
7 Recruiting Safety and Efficacy Study of Hydromorphone HCl by Intrathecal Administration Using a Programmable Implantable Pump
Condition: Management of Chronic Pain
Intervention: Drug: Hydromorphone Hydrochloride
Outcome Measures: Superiority of intrathecal hydromorphone hydrochloride as compared to a control arm.;   Functionality based on a Brief Pain Inventory
8 Recruiting Single-arm Study to Assess the Safety of Hydromorphone HCl by Intrathecal Administration
Condition: Chronic Pain
Intervention: Drug: Hydromorphone Hydrochloride
Outcome Measure: Frequency of Adverse Events during a 12-month period of treatment with intrathecal hydromorphone.
9 Unknown  Safety and Efficacy of Intravenous Hydromorphone in Elderly Emergency Department Patients With Acute Severe Pain
Condition: Pain
Interventions: Drug: Hydromorphone;   Drug: Usual care
Outcome Measure: Proportion with successful treatment
10 Recruiting Intrathecal Hydromorphone for Cesarean Section
Condition: Pain
Intervention: Drug: intrathecal hydromorphone (IT hydromorphone)
Outcome Measures: The primary objective is to find the optimal dose of IT hydromorphone for pain relief following C/S.;   A secondary objective is to define the incidence and severity of hydromorphone's side effects.;   A secondary objective is to determine the duration of analgesia
11 Recruiting Fentanyl for Breakthrough Pain in the Emergency Department
Condition: Pain
Interventions: Drug: Fentanyl Nasal Spray;   Drug: Hydromorphone PCA;   Other: Placebo Nasal Spray
Outcome Measure: Total Pain Relief Score
12 Recruiting Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries
Condition: Pain
Interventions: Drug: Hydromorphone;   Drug: Morphine
Outcome Measures: Change in Pain Scores;   Number of Participants with Adverse Events (AEs)
13 Recruiting True Functional Restoration and Analgesia in Non-Radicular Low Back Pain
Condition: Low Back Pain
Intervention: Drug: Hydromorphone ER
Outcome Measures: The efficacy of Exalgo (hydromorphone HCl extended release) in Chronic Non-Radicular Low Back Pain (CNRBP) model syndrome to improve pain, function and activity;   The relationship between pain ratings and functioning
14 Recruiting Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose
Conditions: Analgesia, Obstetrical;   Cesarean Section
Interventions: Drug: Morphine;   Drug: Hydromorphone
Outcome Measures: Visual analog pain score following spinal anesthesia administration;   Total opioid medication consumption;   Visual analog pain score following administration of spinal anesthesia;   Side effects: Pruritus;   Side effects: Nausea;   Side effects: Sedation
15 Recruiting Multiple Dose Study of Blockade of Opioid Effects of Subcutaneous Injections of Buprenorphine in Participants With Opioid Use Disorder
Condition: Opioid Use Disorder
Interventions: Drug: Buprenorphine;   Drug: buprenorphine and naloxone;   Drug: hydromorphone;   Drug: placebo
Outcome Measures: Opioid Blockade Following Administration of 0, 6, or 18 mg Intramuscular (IM) Hydromorphone As Measured Using the Subjective Opioid Effects Rating for the Question "Do you like the drug?" Visual Analog Scale (VAS);   Reinforcing Effects Of the Daily Randomized Hydromorphone Challenge as Measured by the Mean Hydromorphone Break Point Value;   Relationship between plasma concentration and predicted mu opioid receptor occupancy of buprenorphine and both the blockade of the subjective effects of hydromorphone post injection of buprenorphine 300 mg (RBP-6000);   Summary of Participants with Adverse Events;   Correlation between the opioid blockade subjective effect when participants are asked "Do you feel any drug effect?" and simulated mu opioid receptor occupancy;   Correlation between the opioid blockade subjective effect when participants are asked "Does the drug have any good effects?" and simulated mu opioid receptor occupancy;   Correlation between the opioid blockade subjective effect when participants are asked "Do you like the drug?" and simulated mu opioid receptor occupancy;   Correlation between the opioid blockade subjective effect when participants are asked "Do you feel sedated?" and simulated mu opioid receptor occupancy;   Correlation between the opioid blockade subjective effect when participants are asked "How high are you right now?" and simulated mu opioid receptor occupancy;   Correlation between the opioid blockade subjective effect when participants are asked "Does the drug have any bad effects?" and simulated mu opioid receptor occupancy
16 Recruiting Postoperative Pain Therapy With Hydromorphone Using TCI-PCA
Condition: Postoperative Pain
Intervention: Drug: Hydromorphone
Outcome Measures: Hydromorphone Plasma Concentrations;   Numerical Rating Score
17 Unknown  Trial Comparing Morphine to Hydromorphone in Elderly Patients With Severe Pain
Condition: Acute Pain
Interventions: Drug: Morphine 0.05 mg/kg Intravenous;   Drug: Hydromorphone 0.0075 mg/kg intravenous
Outcome Measures: The between-group difference in before-after improvement in pain scores measured 30 minutes after medications are infused.;   Pain score comparisons at 15 minutes and 120 minutes;   Total mg of additional pain medications required after initial medication;   Pain relief measurement;   Patient satisfaction measurement;   Comparison of adverse events
18 Recruiting Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance
Conditions: Opioid Dependence;   Pain;   Addiction
Interventions: Drug: Placebo;   Drug: Hydromorphone;   Drug: Buprenorphine
Outcome Measures: Cold pressor test.;   Innocuous stimulation.;   Pressure pain.;   Thermal pain.;   Temporal summation.;   Diffuse noxious inhibitory controls (DNIC).;   Visual analog scales (VAS) of subjective drug effects.;   Pupil diameter.;   Number of participants with adverse events.;   Profile of Mood States.;   Vital Signs.;   Trait pain catastrophizing.;   Situational pain catastrophizing.
19 Unknown  Clinical Trial Comparing Two Protocols Using Intravenous (IV) Hydromorphone
Condition: Acute Pain
Interventions: Drug: H2O;   Drug: 1+1
Outcome Measures: Decline additional pain medication;   Number of participants with hypotension (SBP < 90 mmHg);   Number of participants with bradycardia (HR < 50/min);   Number of patients with nausea and vomiting;   Number of participants with pruritus;   Number of participants needing naloxone as a reversal agent
20 Recruiting Epidural Analgesia Versus IV Analgesia in Lumbar Spine Fusions
Conditions: Lumbar Spine Fusion;   Pain;   Back Pain
Interventions: Other: Epidural Catheter - Dilaudid;   Drug: Dilaudid
Outcome Measures: Post-operative pain as assessed by Visual Analogue Scale;   Assessing change in patient functional status with regards to depression, anxiety, and pain;   Patient satisfaction with peri-operative care;   Patient satisfaction with perioperative analgesia;   Number of participants with adverse events